Skip to main content Skip to search Skip to main navigation

Data Integrity and Data Governance

Excerpt from the GMP Compliance Adviser, Chapter 15.H,Data integrity – general requirements in a GxP-regulated environment

4 min. reading time | by Markus Veit, PhD
Published in LOGFILE 24/2025 

Data integrity is a key element in the pharmaceutical quality assurance system which has gained importance in recent years, especially from the viewpoint of the authorities. In GxP-regulated companies, managers are responsible for identifying and minimising risks to data integrity (“data governance”).


What is the importance of data integrity?

Data integrity plays a key role in the fundamental requirements that affect a pharmaceutical quality system as specified in Chapter 1 of the EU GMP Guidelines. As a result, the senior management of a pharmaceutical company must provide the necessary resources and ensure that all of the principal requirements are implemented. This also applies to all the suppliers, contract manufacturers, contract laboratories and logistics companies that work with the pharmaceutical company.


A risk-based approach also applies to data integrity!

A risk-based approach should always be taken that complies with the principles of pharmaceutical quality risk management (ICH Q9(R1)). This also includes carrying out regular evaluations to check if the actions taken are appropriate and sufficient. The criticality of the data examined during this process is very important and should be carefully evaluated. It is obvious that the data used when making a decision on batch release is more critical than data that is not directly relevant to the release, such as warehouse cleaning records.


Which measures are crucial for implementation and monitoring of data integrity?

To comply with the requirements of data integrity, suitable monitoring systems must be in place. In addition, regular personnel training on the importance of data integrity principles must be carried out. The training sessions should contribute to the creation of a working environment that promotes an open culture of reporting failures, omissions and deviating results.


What responsibilities does management have?

In GxP-controlled companies, management is responsible for implementing systems and procedures for minimising the potential risk to data integrity and to identify risks using risk-based principles ("data governance").

The PIC/S guideline PI 041-1 „Good Practices for Data Management and Integrity in Regulated GMP/GDP-Environments“ assigns clear tasks and responsibilities to senior management in this regard:

  • Leadership, resource allocation and financing for the data integrity and data governance initiative within a company. This programme requires more than just an email from the CEO stating that the company will ensure data integrity from now on; rather, it requires a concerted and long-term effort.
  • Creation of an open company culture, where the staff members have the opportunity to address integrity issues.
  • Establishment and maintenance of a quality culture.
  • Determining and maintaining the ethos and values for data integrity.
  • Definition of guidelines and procedures with the corresponding training for all aspects of data integrity.
  • Ensuring that assessments of processes and systems are carried out to identify and classify data vulnerabilities.
  • Establishment of metrics for various data integrity activities and review by management.
  • Completion of regular and sound reviews of data integrity projects.
  • Establishment of a protected whistle-blower procedure to make the senior management aware of data integrity issues.

Data Integrity and Supplier qualification

Contract givers should ensure as part of supplier qualification that appropriate systems are also implemented at all of their suppliers. In the case of contract manufacturing, contract testing and contract packaging, this also includes monitoring measures and regular checks that cover the following aspects as a minimum:

  • trend recording and systematic follow-up of non-compliant and deviating data as specified in the life-cycle concepts now required during pharmaceutical development, validation and monitoring of analytic procedures and manufacturing processes
  • regular checks of audit trails which help detect possible deviations and situations that necessitate additional training measures
  • validation and routine monitoring of computerised systems as outlined in Annex 11 of the EU GMP Guidelines

Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Markus Veit
Dr. Markus Veit

You may also be interested in the following articles:

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic has revised its guidance document “GMP compliance by foreign manufacturers”. The new Version 7.0 has been valid since 7 September 2026. In particular, it introduces new provisions for demonstrating the GMP compliance of manufacturers inspected by the US FDA. 
Read more
Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic has revised its Technical Interpretation “Market release and distribution in cooperation with a pre-wholesaler”. The document addresses market release and distribution where a Marketing Authorisation Holder works with a pre-wholesaler (logistics and distribution service provider).
Read more
News: Europe

IPEC Updates Two Guides on Pharmaceutical Excipients

The IPEC Federation has updated two key guides on pharmaceutical excipients. The IPEC Composition Guide for Pharmaceutical Excipients (Version 3, 2026) describes an approach for manufacturers to establish excipient composition profiles. The revised version now covers biotechnology- and fermentation-derived excipients, provides further details on component types and physicochemical characterisation, and includes an example composition profile template.
Read more
Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Artificial intelligence is becoming increasingly important in GMP-regulated environments, presenting companies with new regulatory challenges. This article summarizes the latest regulatory developments, introduces a validation framework based on the FDA's seven-step model, and outlines initial practical experience with AI/ML validation.

Read more
Question of the Week | GMP-Verlag

What are the General Requirements for Standard Documents?

Here's the answer:
Read more
News: Europe

EDQM: Revised Guidance on Sister File Applications

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its Guidance on applications for “sister files” (PA/PH/CEP (09) 141). The revision is intended to support consistent application of the procedure and provide greater clarity on the classification and assessment of the corresponding CEP applications.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more.  Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

delivery time appr. 2-5 workdays after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery time appr. 2-5 workdays after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT